Accessibility Menu
KORU Medical Systems logo

KORU Medical Systems(NASDAQ) KRMD

Market Cap$148.21MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1990)+8,075%
5 Year-0%
1 Year-22%
1 Month-17%
Premium Feature
Moneyball Superscore
68/100
$3.21
-1.83%
-0.06Today
KORU Medical Systems last closing stock price
MetricPriceDate
Last closeUSD 3.212026-08-21
KORU Medical Systems stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-5.59%USD 3.402026-08-14
1 month-16.84%USD 3.862026-07-22
3 month-21.71%USD 4.102026-05-22
Year to date-44.75%USD 5.812025-12-31
1 year-21.9%USD 4.112025-08-21
3 year+24.9%USD 2.572023-08-22
5 year-0.31%USD 3.222021-08-20
Since inception+8,075%USD 0.041990-12-28

KORU Medical Systems Financials at a Glance

Market Cap

$148.21MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$45.11M

Net Income (TTM)

-$1.82M

EPS (TTM)

-$0.04

P/E Ratio

-81.06

Dividend

$0.00

Beta (Volatility)

0.93 (Low)

Price

$3.21

Volume

235,173.702

Open

$3.27

Previous Close

$3.21

Daily Range

$3.20 - $3.30

52-Week Range

$3.20 - $6.61

Estimated Earnings Date

Nov 11, 2026

KRMD News

Businessman looking at line going through floor

Why Repro Med Stock Is Sinking Today

Keith SpeightsJan 26, 2021

KRMD: Motley Fool Moneyball Superscore

68

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About KORU Medical Systems

KORU Medical makes portable devices for people needing regular medicine infusions. Its products help patients treat conditions at home, not just in hospitals. The company’s systems are used for diseases needing frequent drug delivery, like immune disorders.

Gadgets That Matter: KORU’s Main Offerings

  • Core business (domestic and international) accounted for 91% of Q2 2025 revenue.
  • HIgH-Flo Safety Needle Sets: Needles designed for safe, comfortable subcutaneous (under the skin) infusions.
  • Precision Flow Rate Tubing: Tubing that controls how fast medicine enters the body.
  • Pharma Services & Clinical Trials: Custom device solutions for drug companies; 9% of Q2 2025 revenue.
  • Education & Training: Materials for patients and healthcare workers to use devices safely and effectively.

Growth Moves: KORU’s Expansion Playbook

  • Expanded internationally, with international sales up 33.9% year-on-year in Q2 2025.
  • Increased investment in research, new product lines, and manufacturing equipment in 2025.
  • Broadened pharma services and clinical trials business, offering custom device engineering for drug makers.
  • Entered new global markets, supporting the shift to home-based care since 2023.

Why KORU Stands Out (Without the Hype)

KORU’s devices support the trend toward home and outpatient care, making regular treatments easier for patients. Its global distribution and regulatory approvals allow access to both U.S. and international markets. The company’s focus on mechanical, non-electric devices offers reliability for users needing frequent infusions.

Five Things You Need to Know

  • Q2 2025 revenue was $10.2 million, up 20.9% from Q2 2024.
  • Core business made up 91% of Q2 2025 revenue; pharma services 9%.
  • International sales grew 33.9% year-on-year in Q2 2025.
  • Q2 2025 net loss was $0.2 million, improved 79.1% from Q2 2024.
  • Gross margin was 63.5% in Q2 2025, down from 65.0% in Q2 2024.

Bottom Line

KORU has grown by focusing on home infusion devices and expanding globally. The company’s steady revenue growth and product innovation support its position in the medical device market.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

73

CEO

Linda M. Tharby

Website

www.korumedical.com

Headquarters

Mahwah, NY 07430, US

KRMD Financials

Key Financial Metrics (TTM)

Gross Margin

61.99%

Operating Margin

-3.66%

Net Income Margin

-4.03%

Return on Equity

-10.63%

Return on Capital

-14.47%

Return on Assets

-6.51%

Earnings Yield

-1.23%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$148.21MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

46.17M

Volume

235.17K

Avg. Volume

183.41K

Financials (TTM)

Gross Profit

$27.96M

Operating Income

-$1.65M

EBITDA

-$1.02M

Operating Cash Flow

$1.39M

Capital Expenditure

-$1.13M

Free Cash Flow

$263.47K

Cash & ST Invst.

$8.29M

Total Debt

$3.24M

KORU Medical Systems Performance Analysis

KORU Medical Systems annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 27,896,03718.8%
20232023-12-31USD 28,517,6662.2%
20242024-12-31USD 33,646,46318.0%
20252025-12-31USD 41,127,36622.2%
KORU Medical Systems sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-302.0%
Q42025-12-314.7%
Q12026-03-318.0%
Q22026-06-302.4%
KORU Medical Systems annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.1987.3%
20232023-12-31USD -0.3056.5%
20242024-12-31USD -0.13-56.0%
20252025-12-31USD -0.06-56.9%
KORU Medical Systems sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-273.3%
Q42025-12-3137.5%
Q12026-03-31-65.7%
Q22026-06-30129.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$12.05M

+18.2%

Gross Profit

$7.85M

+21.2%

Gross Margin

65.14%

N/A

Market Cap

$148.21MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$2.03M

N/A

Employees

73

N/A

Net Income

$252.45K

+222.0%

EBITDA

$468.28K

+2244.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$8.29M

+2.9%

Total Debt

$3.24M

-6.6%

Accounts Receivable

$6.09M

+19.7%

Inventory

$4.51M

+14.3%

Long Term Debt

$2.66M

-9.5%

Short Term Debt

$578.77K

+9.7%

Return on Assets

-6.51%

N/A

Return on Invested Capital

-7.95%

N/A

Free Cash Flow

-$361.25K

+26.1%

Operating Cash Flow

$216.11K

+146.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MXCTMaxCyte, Inc.
$1.38+0.00%
NYXHNyxoah S.A.
$1.60-2.44%
STIMNeuronetics, Inc.
$3.00-2.91%
UTMDUtah Medical Products, Inc.
$71.55+0.18%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.77+0.10%
IBITiShares Bitcoin Trust
$43.68+0.06%
BITOProShares Trust - ProShares Bitcoin ETF
$10.41+0.06%
MARAMara Holdings
$11.26+0.01%

Questions About KRMD

What is the current price of KORU Medical Systems?

KORU Medical Systems is trading at $3.21 per share.

What is the 52-week range for KORU Medical Systems?

Over the past 52 weeks, KORU Medical Systems has traded between $3.20 and $6.61.

How much debt does KORU Medical Systems have?

As of the most recent reporting period, KORU Medical Systems reported total debt of $3.31M.

How much cash does KORU Medical Systems have on hand?

KORU Medical Systems reported $8.29M in cash and cash equivalents in its most recent financial results.

What is KORU Medical Systems’s dividend yield?

KORU Medical Systems does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services